What is the difference between fms and cfs

Scand J Rheumatol ; 22 : 35 —8. Chronic fatigue syndrome differs from fibromyalgia. No evidence for elevated substance P levels in cerebrospinal fluid of patients with chronic fatigue syndrome.

Pain ; 78 : —5. Cardiovascular response to upright tilt in fibromyalgia differs from that in chronic fatigue syndrome. J Rheumatol ; 28 : — Enhanced sensitivity of the peripheral cholinergic vascular response in patients with chronic fatigue syndrome.

Am J Med ; : —9. Prolonged acetylcholine-induced vasodilatation in chronic fatigue syndrome. Clin Physiol, in press. Investigation of cutaneous microvascular activity and flare response in patients with fibromyalgia syndrome.

Rheumatology ; 40 : —1. The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Intern Med ; : —9. Evidence for and pathophysiologic implications of hypothalamic—pituitary—adrenal axis dysregulation in fibromyalgia and chronic fatigue syndrome. Ann NY Acad Sci ; : — Oxford University Press is a department of the University of Oxford.

It furthers the University's objective of excellence in research, scholarship, and education by publishing worldwide. Sign In or Create an Account. Sign In. Advanced Search. Search Menu. Article Navigation. Hayes, J.

McCord, and M. Light, R. Hughen, J. Zhang, J. Rainier, Z. Liu, and J. Tsuda, Y. Shigemoto-Mogami, S. Koizumi et al. Ulmann, J. Hatcher, J. Hughes et al. Ulmann, H. Hirbec, and F. Zhang, Z. Zhang, U. Fauser, and H. Fujii, N. Ozaki, T. Taguchi, K. Mizumura, K. Furukawa, and Y. Frank, B. Niesler, B. Bondy et al. Tander, S. Gunes, O. Boke et al. Nicholl, K. Holliday, G. MacFarlane et al. Macfarlane, B. Nicholl, F. Creed, W. Thomson, and J. Weaver, M. Janal, N. Aktan, J. Ottenweller, and B. Lee, S.

Choi, J. Ji, and G. In press. Erdal, H. Herken, E. Madenci, B. View at: Google Scholar H. Cohen, L. Neumann, Y. Glazer, R. Ebstein, and D. S51—S56, View at: Google Scholar P. Finan, A. Zautra, M. Davis, K. Lemery-Chalfant, J.

Covault, and H. Diatchenko, G. Slade, A. Nackley et al. Andersen and F. Nackley, K. Tan, K. Fecho, P. Flood, L. Diatchenko, and W. Nackley, S. Shabalina, J. Lambert et al. Hagen, E. Pettersen, L. Stovner, F. Skorpen, and J. Macfarlane et al. Fragoso, D. Cruz-Robles et al. Herlyn, B. Wendt, M.

Hecker, T. Mittlmeier, and G. Kim, M. Camilleri, P. Carlson et al. Xiao, W. He, and I. Light, E. Bragdon, K. Grewen, K. Brownley, S. Girdler, and W. Tchivileva, P. Lim, S.

Smith et al. Zubieta, M. Heitzeg, Y. Wood, P. Schweinhardt, E. Jaeger et al. Treister, D. Pud, R. Ebstein et al. Ablin, A. Bar-Shira, M. Yaron, and A. S33—S38, View at: Google Scholar M. Mochi, S. Cevoli, P. Cortelli et al. Symptoms and Diagnosis. Information for Healthcare Providers.

Links with this icon indicate that you are leaving the CDC website. Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website. Measure content performance. Develop and improve products. List of Partners vendors. The word "syndrome" has been so misused in the popular media that it carries a connotation of being made up, silly, or overblown.

Meanwhile, "disease" sounds ominous and scary. It's common for people who don't believe in these conditions to dismissively say they are not really "diseases. The classification, though, has no bearing on whether they exist or how serious they are. It's simply a matter of how well they're understood.

So what's the difference? The definition of syndrome is pretty straight forward: a collection of signs and symptoms known to frequently appear together. We're learning more about the various physiological problems associated with FMS—such as neurotransmitter dysregulation and immune system irregularities—but so far, researchers have not uncovered the underlying cause or causes of these problems. This is one reason FMS isn't classified as a disease.

However, as we gain more knowledge, we're likely getting closer to re-classification.